AgilVax's Incubator/Accelerator - II Round

AgilVax raised a round of funding on April 16, 2018. Investors include JLabs.

Agilvax develops targeted vaccine therapies based on its virus-like particle (VLP) platform technology. Agilvax is a biotechnology company employing a vaccine discovery platform to develop safe and ef…

Articles about AgilVax's Incubator/Accelerator - II Round: